NPI: 1215176433 · WINTER PARK, FL 32792 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/11/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/11/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,313 | $2.36M |
| 2019 | 14,647 | $2.86M |
| 2020 | 23,167 | $1.63M |
| 2021 | 13,809 | $38K |
| 2022 | 4,249 | $141K |
| 2023 | 5,641 | $116K |
| 2024 | 3,473 | $184K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,710 | 1,582 | $2.23M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,589 | 1,140 | $2.19M |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,087 | 842 | $1.46M |
| A4657 | Syringe, with or without needle, each | 2,973 | 1,245 | $476K |
| J1756 | Injection, iron sucrose, 1 mg | 5,583 | 991 | $411K |
| 85048 | 1,238 | 618 | $131K | |
| 85041 | 1,070 | 651 | $127K | |
| 83970 | 819 | 500 | $97K | |
| 82728 | 507 | 324 | $60K | |
| 83540 | 539 | 342 | $57K | |
| 83550 | 365 | 223 | $37K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 475 | 161 | $18K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 221 | 96 | $9K |
| 82607 | 47 | 26 | $6K | |
| 82746 | 47 | 27 | $6K | |
| 82108 | 13 | 13 | $5K | |
| 90674 | 16 | 14 | $5K |